Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Terminated 2Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Carcinoma, Hepatocellular 3Liver Neoplasms 1

Interventions

Sorafenib 52pembrolizumab 26Nivolumab 20Bevacizumab 19Radiosurgery 17Doxorubicin 12atezolizumab 9Erlotinib Hydrochloride 9lenvatinib 8cabozantinib 7Magnetic Resonance Spectroscopy 7tremelimumab 6durvalumab 6Ramucirumab 6Radiofrequency Ablation 6Cisplatin 6Sunitinib 5tislelizumab 4regorafenib 4Oxaliplatin 4Leucovorin 4Ipilimumab 4Fluorouracil 4Everolimus 4Capecitabine 4nintedanib 3fluoromisonidazole 3carotuximab 3bavituximab 3Tomography, X-Ray Computed 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has results × Carcinoma, Hepatocellular × Ethiodized Oil × Clear all
NCT02762266 2024-03-12

Transarterial Chemoembolization Compared With Stereotactic Body Radiation Therapy or Stereotactic Ablative Radiation Therapy in Treating Patients With Residual or Recurrent Liver Cancer Undergone Initial Transarterial Chemoembolization

Stanford University

Phase 3 Terminated
13 enrolled 12 charts
Gastrointestinal

Carcinoma, Hepatocellular

NCT01387932 2021-11-30

HiQuality

Merit Medical Systems, Inc.

Phase 3 Terminated
235 enrolled 11 charts
Gastrointestinal

Carcinoma, Hepatocellular

NCT01877187 2020-04-15

Lipiodol as an Imaging Biomarker in Patients With Primary and Metastatic Liver Cancer

Yale University

Phase 2 Completed
39 enrolled 14 charts
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡